Eliminating the category II retreatment regimen from national tuberculosis programme guidelines: the Georgian experience
Jennifer Furin, Iagor Kalandadze(National Center for Tuberculosis and Lung Disease), Rocio Hurtado(Harvard University), Jacob Joseph(Lourdes Hospital), Carole D. Mitnick(Brigham and Women's Hospital), Medea Gegia(World Health Organization), Michael Rich(Partners In Health), Peter Drobac(University of Oxford), Mercedes C. Becerra(Brigham and Women's Hospital), Paul Farmer(Harvard University), Sonya Shin(Brigham and Women's Hospital), Salmaan Keshavjee(Brigham and Women's Hospital)
Cited by 25
Related Papers
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
|Clinical Infectious Diseases|2016|1.5k
Structural Violence and Clinical Medicine
|PLoS Medicine|2006|1.1k
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
|The Lancet|2018|639